<div id="readability-page-1"><p>Shares of Clover Health Investments, Corp. (NASDAQ:CLOV - Get Free Report) have been assigned a consensus recommendation of &#34;Moderate Buy&#34; from the six analysts that are  covering the firm, Marketbeat reports. One analyst  has rated the stock with a sell recommendation, two have issued  a hold recommendation, two have issued  a buy recommendation and one  has assigned  a strong buy recommendation to  the company. The average 12-month price target among brokers that have updated their coverage on the stock in the last year is $3.9250.</p><ul><li>MarketBeat Week in Review – 03/03 - 03/07</li></ul><p>Several equities analysts have commented on the company. Zacks Research raised Clover Health Investments from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a research report on Friday, October 24th. Weiss Ratings  reissued a &#34;sell (d-)&#34; rating on shares of Clover Health Investments in a research note on Wednesday. Canaccord Genuity Group reduced their price target on shares of Clover Health Investments from $4.10 to $3.70 and set a &#34;buy&#34; rating on the stock in a research note on Thursday, November 6th. Wall Street Zen lowered shares of Clover Health Investments from a &#34;hold&#34; rating to a &#34;sell&#34; rating in a report on Saturday, November 15th. Finally, Leerink Partners  set a $3.00 target price on shares of Clover Health Investments and gave the stock a &#34;market perform&#34; rating in a research note on Tuesday, October 21st.</p><p><b>Read Our Latest Report on CLOV</b></p><h2>Institutional Investors Weigh In On Clover Health Investments</h2><ul><li>Missed the Hims &amp; Hers Rally? Clover Health Could Be Next</li></ul><p>A number of institutional investors and hedge funds have recently bought and sold shares of CLOV. Vanguard Group Inc. grew its position in shares of  Clover Health Investments by 5.1% during the 1st quarter. Vanguard Group Inc. now owns 20,580,117 shares of the company's stock worth $73,883,000 after buying an additional 994,904 shares in the last quarter.  Geode Capital Management LLC grew its holdings in  Clover Health Investments by 95.7% during the 2nd quarter. Geode Capital Management LLC now owns 9,843,349 shares of the company's stock worth $27,467,000 after acquiring an additional 4,812,368 shares in the last quarter.  Millennium Management LLC increased its position in  Clover Health Investments by 365.9% during the 1st quarter. Millennium Management LLC now owns 5,804,006 shares of the company's stock valued at $20,836,000 after purchasing an additional 4,558,305 shares during the period.  Bank of America Corp DE increased its position in  Clover Health Investments by 217.5% during the 2nd quarter. Bank of America Corp DE now owns 4,012,744 shares of the company's stock valued at $11,196,000 after purchasing an additional 2,748,783 shares during the period.  Finally, Divisadero Street Capital Management LP bought a new stake in shares of  Clover Health Investments in the 3rd quarter valued at about $8,470,000. 19.77% of the stock is owned by institutional investors. </p><h2>Clover Health Investments Trading Up 5.6%</h2><p>Clover Health Investments stock opened at $2.28 on Friday. Clover Health Investments has a 12-month low of $2.12 and a 12-month high of $4.87. The firm has a 50-day moving average price of $2.92 and a 200-day moving average price of $2.94. The firm has a market capitalization of $1.18 billion, a PE ratio of -20.73 and a beta of 2.07. </p><p>Clover Health Investments (NASDAQ:CLOV - Get Free Report) last posted its quarterly earnings data on Tuesday, November 4th. The company reported ($0.05) earnings per share for the quarter, missing analysts' consensus estimates of $0.02 by ($0.07). Clover Health Investments had a negative return on equity of 16.79% and a negative net margin of 3.29%.The firm had revenue of $496.65 million during the quarter, compared to analysts' expectations of $467.18 million.  As a group, sell-side analysts predict that  Clover Health Investments will post -0.12 earnings per share for the current fiscal year. </p><h2>About Clover Health Investments</h2> (Get Free Report)<p>Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.</p><h2>Featured Stories</h2><ul><li>Five stocks we like better than Clover Health Investments</li><li>ETF Screener: Uses and Step-by-Step Guide </li><li>Rocket Lab Just Had Its First Real Crash—The Rebound Could Be Bigger</li><li>P/E Ratio Calculation: How to Assess Stocks</li><li>MarketBeat Week in Review – 11/17 - 11/21</li><li>What does consumer price index measure? </li><li>A Magnificent AI Bet? Stanley Druckenmiller’s Latest Tech Moves</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q0xPVg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="600" height="385" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q0xPVg"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Clover Health Investments Right Now?</h2><p>Before you consider Clover Health Investments, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clover Health Investments wasn't on the list.</p><p>While Clover Health Investments currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

CLOV

<p>Clover Health Investments, Corp. (NASDAQ:CLOV) has received a consensus "Moderate Buy" recommendation from six analysts. The stock's average 12-month price target is $3.9250. Analysts' ratings vary, with one "sell," two "hold," two "buy," and one "strong buy." Institutional investors have increased their holdings, with notable growth from Vanguard Group and Geode Capital Management. The stock opened at $2.28, with a market cap of $1.18 billion. Recent earnings missed estimates, reporting a loss of $0.05 per share.</p>

Clover Health Investments, Corp. (NASDAQ:CLOV) Given Consensus Recommendation of "Moderate Buy" by Brokerages